Rockwell Medical (RMTI) Change in Accured Expenses (2010 - 2026)

Rockwell Medical's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 11.97% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 95.25% YoY) and the FY2025 annual result came in at -$1.7 million, down 62.38% from the prior year.
• Change in Accured Expenses was -$1.5 million for Q1 2026 at Rockwell Medical, down from $625000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $2.9 million in Q3 2023 and bottomed at -$3.3 million in Q1 2023.
• A 5-year average of -$118705.9 and a median of -$139000.0 in 2025 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses slumped 414.84% — and 2025, when it soared 320.85%.
• Rockwell Medical's Change in Accured Expenses stood at $1.8 million in 2022, then slumped by 63.05% to $657000.0 in 2023, then slumped by 143.07% to -$283000.0 in 2024, then surged by 320.85% to $625000.0 in 2025, then tumbled by 334.08% to -$1.5 million in 2026.
• Business Quant data shows RMTI's Change in Accured Expenses at -$1.5 million in Q1 2026, $625000.0 in Q4 2025, and -$139000.0 in Q3 2025.